drugset / Trial / NCT03251729

Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix

NCT03251729

Phase 4 Completed 93 enrolled Thomas Jefferson University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the efficacy of cervical cerclage in prevention of spontaneous preterm birth in singleton pregnancies with a short transvaginal cervical length (\<=25mm) and without prior spontaneous preterm birth

Timeline

Start
2017-09-22
Primary completion
2024-02-20
Completion
2024-02-20

Drugs

EvaluationDrugModalityDoseRoute
Background Progesterone Other / unclassified 90 mg Other
Background Progesterone Other / unclassified 200 mg Other

Indications

No indication recorded.